National Institute for Health and Care Excellence
PUBLIC HEALTH GUIDELINES –Sunlight exposure - risks and benefits2nd Consultation on the Draft Guideline from 09 July – 06 August 2015 Comments
to be received no later than 5pm on 06 August 2015
Please note you may find it easier to complete this form by changing the layout
of the word document to ‘Draft’. You can do this by clicking “View” and selecting
“Draft”. If you have any queries please feel free to contact us.
Stakeholder Comments
Please use this form for submitting your comments to the Institute.
1. Please put each new comment in a new row.
2. Please insert the section number (eg 3.2) in the 1st column. If your comment relates to the
document as a whole, please put ‘general’ in this column
3. Please insert the page number (ie ‘7’) in the 2nd column.
4. Please note forms with attachments such as research articles, letters or leaflets will not be
accepted. If forms are received with an attachment they will be returned without being
read. Any resubmitted forms without attachments must be by the consultation deadline.
Name:
Organisation:
Section number
Page
Number
Indicate section
number or ‘general’
if your comment
relates to the whole
document
Heidi Wright
Royal Pharmaceutical Society
Comments
Please insert each new comment in a new row.
Section 1.1.10
7
Section 1.1.13
7
Pharmacies are an ideal location to promote public health
messages including those on sunlight exposure so they should
be considered as an option.
The current community pharmacy contractual framework allows
for co-ordinated local public health campaigns in local community
pharmacies so this should also be considered as a route for
promoting this campaign.
Please add extra rows as needed
Please return the comments form to: [email protected]
NB: The Institute reserves the absolute right to edit, summarise or remove comments received on during consultation
on draft guidelines where, in the reasonable opinion of the Institute, they may conflict with the law, are voluminous or
are otherwise considered inappropriate.
National Institute for Health and Care Excellence
PUBLIC HEALTH GUIDELINES –Sunlight exposure - risks and benefits2nd Consultation on the Draft Guideline from 09 July – 06 August 2015 Comments
to be received no later than 5pm on 06 August 2015
Please note you may find it easier to complete this form by changing the layout
of the word document to ‘Draft’. You can do this by clicking “View” and selecting
“Draft”. If you have any queries please feel free to contact us.
Stakeholder Comments
Please use this form for submitting your comments to the Institute.
1. Please put each new comment in a new row.
2. Please insert the section number (eg 3.2) in the 1st column. If your comment relates to the
document as a whole, please put ‘general’ in this column
3. Please insert the page number (ie ‘7’) in the 2nd column.
4. Please note forms with attachments such as research articles, letters or leaflets will not be
accepted. If forms are received with an attachment they will be returned without being
read. Any resubmitted forms without attachments must be by the consultation deadline.
Name:
Organisation:
Section number
Page
Number
Indicate section
number or ‘general’
if your comment
relates to the whole
document
Section 2
Heidi Wright
Royal Pharmaceutical Society
Comments
Please insert each new comment in a new row.
12
At present there is a huge range of unlicensed food
supplement Vit D products on the market and relatively few
products licensed by MHRA as medicines (GSL, P, or POM).
Until recently there were no high dose licensed Vit D products
available.
Currently licensed products are available both for routine
supplementation in at risk groups and for the treatment of
insufficiency. There is a distinction between unlicensed (and
largely unregulated) food supplements and licensed medicines
and the RPS believes that this distinction should be made as
part of this guidance. The guidance should also highlight that
licensed Vit D products are now available and that these are
the ones that should be prescribed and supplied.
The MHRA hierarchy of risk places a product licensed in
another country above a UK manufactured food supplement
and many hospitals have been importing from other European
countries where a licensed product is available.
Please add extra rows as needed
Please return the comments form to: [email protected]
NB: The Institute reserves the absolute right to edit, summarise or remove comments received on during consultation
on draft guidelines where, in the reasonable opinion of the Institute, they may conflict with the law, are voluminous or
are otherwise considered inappropriate.
National Institute for Health and Care Excellence
PUBLIC HEALTH GUIDELINES –Sunlight exposure - risks and benefits2nd Consultation on the Draft Guideline from 09 July – 06 August 2015 Comments
to be received no later than 5pm on 06 August 2015
Please note you may find it easier to complete this form by changing the layout
of the word document to ‘Draft’. You can do this by clicking “View” and selecting
“Draft”. If you have any queries please feel free to contact us.
Stakeholder Comments
Please use this form for submitting your comments to the Institute.
1. Please put each new comment in a new row.
2. Please insert the section number (eg 3.2) in the 1st column. If your comment relates to the
document as a whole, please put ‘general’ in this column
3. Please insert the page number (ie ‘7’) in the 2nd column.
4. Please note forms with attachments such as research articles, letters or leaflets will not be
accepted. If forms are received with an attachment they will be returned without being
read. Any resubmitted forms without attachments must be by the consultation deadline.
Name:
Organisation:
Section number
Page
Number
Indicate section
number or ‘general’
if your comment
relates to the whole
document
Heidi Wright
Royal Pharmaceutical Society
Comments
Please insert each new comment in a new row.
If food supplements are used instead of licensed vit D products
there is a major concern that people will not get the appropriate
dose.
The MHRA has assayed available vitamin D products and found
variations between 14.3% and 149.6% of the stated content
amongst the food supplements. This variability does not happen
with licensed products.
Please add extra rows as needed
Please return the comments form to: [email protected]
NB: The Institute reserves the absolute right to edit, summarise or remove comments received on during consultation
on draft guidelines where, in the reasonable opinion of the Institute, they may conflict with the law, are voluminous or
are otherwise considered inappropriate.
National Institute for Health and Care Excellence
PUBLIC HEALTH GUIDELINES –Sunlight exposure - risks and benefits2nd Consultation on the Draft Guideline from 09 July – 06 August 2015 Comments
to be received no later than 5pm on 06 August 2015
Please note you may find it easier to complete this form by changing the layout
of the word document to ‘Draft’. You can do this by clicking “View” and selecting
“Draft”. If you have any queries please feel free to contact us.
Stakeholder Comments
Please use this form for submitting your comments to the Institute.
1. Please put each new comment in a new row.
2. Please insert the section number (eg 3.2) in the 1st column. If your comment relates to the
document as a whole, please put ‘general’ in this column
3. Please insert the page number (ie ‘7’) in the 2nd column.
4. Please note forms with attachments such as research articles, letters or leaflets will not be
accepted. If forms are received with an attachment they will be returned without being
read. Any resubmitted forms without attachments must be by the consultation deadline.
Name:
Organisation:
Section number
Page
Number
Indicate section
number or ‘general’
if your comment
relates to the whole
document
Section 2
Heidi Wright
Royal Pharmaceutical Society
Comments
Please insert each new comment in a new row.
13
The RPS believes that the current sunscreen labelling is causing
a huge amount of confusion which could be a barrier to people
selecting the most effective sun protection. Many people do not
realise the SPF rating applies only to the amount of protection
offered against UVB rays, not UVA rays – both of which can
damage the skin and cause skin cancer. We believe that people
should not have to pick their way through complicated dual
ratings information to understand how sunscreen works and the
amount of protection potentially provided. It is time for sunscreen
manufacturers to provide one easy to understand rating, based
on a simple description of the total amount of sun protection
offered: low (SPF 6-14), medium (SPF 15-29), high (SPF 30-50)
and very high protection (SPF of 50+). Basically the RPS would
like to propose - a very high, high, medium and low ranking for
UVB protection with each sunscreen having what is considered to
be a similar level of UVA protection. This would mean that there
is no confusing star ranking for UVA.
Please add extra rows as needed
Please return the comments form to: [email protected]
NB: The Institute reserves the absolute right to edit, summarise or remove comments received on during consultation
on draft guidelines where, in the reasonable opinion of the Institute, they may conflict with the law, are voluminous or
are otherwise considered inappropriate.
National Institute for Health and Care Excellence
PUBLIC HEALTH GUIDELINES –Sunlight exposure - risks and benefits2nd Consultation on the Draft Guideline from 09 July – 06 August 2015 Comments
to be received no later than 5pm on 06 August 2015
Please note you may find it easier to complete this form by changing the layout
of the word document to ‘Draft’. You can do this by clicking “View” and selecting
“Draft”. If you have any queries please feel free to contact us.
Stakeholder Comments
Please use this form for submitting your comments to the Institute.
1. Please put each new comment in a new row.
2. Please insert the section number (eg 3.2) in the 1st column. If your comment relates to the
document as a whole, please put ‘general’ in this column
3. Please insert the page number (ie ‘7’) in the 2nd column.
4. Please note forms with attachments such as research articles, letters or leaflets will not be
accepted. If forms are received with an attachment they will be returned without being
read. Any resubmitted forms without attachments must be by the consultation deadline.
Name:
Organisation:
Section number
Page
Number
Indicate section
number or ‘general’
if your comment
relates to the whole
document
Heidi Wright
Royal Pharmaceutical Society
Comments
Please insert each new comment in a new row.
In a survey this year of 2,000 GB adults only 8% of those
surveyed knew that the SPF rating on the product label refers to
protection from UVB rays only – and does not also include
protection from harmful UVA rays – typically indicated by a
separate ‘star’ rating. More than 80% said they either thought the
SPF was an indication of levels of protection from both UVB and
UVA (56%) or they simply did not know what the rating stood for
(25%).
Less than a third of those surveyed said they always checked the
UVA star rating when buying sunscreen (31%), and 20% of
students and 15% of adults with children in their household
admitted that they never checked it.
Please add extra rows as needed
Please return the comments form to: [email protected]
NB: The Institute reserves the absolute right to edit, summarise or remove comments received on during consultation
on draft guidelines where, in the reasonable opinion of the Institute, they may conflict with the law, are voluminous or
are otherwise considered inappropriate.